J Merino Alonso

Final results from the PERUSE study of first-line pertuzumab plus trastuzumab plus a taxane for HER2-positive locally recurrent or metastatic breast cancer, with a multivariable approach to guide prognostication

David Miles, Eva Ciruelos, Fabio Puglisi et al. · Annals of Oncology · 2021 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

Cryptococcal cellulitis in an immunocompetent host

Begoña Sánchez‐Albisua, José Luis Rodríguez‐­Peralto, Guillermo Romero et al. · Journal of the American Academy of Dermatology · 1997 · 20 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors

José María Serrano Sanz, Rebeca Mata, Iria González et al. · International Journal of Cardiology · 2023 · 13 citations

Medicine, Oncology, Pharmacology +16

The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world use

Julio Martínez-Cutillas, Carme Alerany-Pardo, Joaquín Borrás‐Blasco et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 2015 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +17